[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "One vaccine dose and two viral variants", "description": "Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine \n\nhttps://www.nejm.org/doi/full/10.1056/NEJMoa2034577\n\nNEJM, (December 31st)\n\nA two-dose regimen of BNT162b2 conferred 94.8% protection against Covid-19 in persons 16 years of age or older\n\nAfter 1 dose, efficacy = 52.4%\n\nNEJM, (17th February)\n\nBut if you take data after 2 weeks \u2026. \n\nhttps://www.nejm.org/doi/pdf/10.1056/NEJMc2036242?articleTools=true\n\nOne Pfizer dose, vaccine efficacy of 92.6% (based on FDA data)\n\nOne Moderna dose, vaccine efficacy of 92.1% (based on FDA data)\n\nUncertainty about duration of protection with a single dose\n\nAdministration of a second dose within 1 month, little added benefit in the short term\n\nLeaving high risk groups completely unprotected\n\nPostponement of the second dose is a matter of national security that, \n\nif ignored, will certainly result in thousands of Covid-19\u2013related hospitalizations and deaths this winter in the United States\n\nhospitalizations and deaths that would have been prevented with a first dose of vaccine. \n\nNZ and Australia begin vaccine rollout\n\nSaturday\n\nBorder staff\n\nManaged Isolation and Quarantine (MIQ) workers\n\nAustralia, Monday\n\nHotel quarantine and healthcare workers\n\nPfizer\n\nPfizer BioNTech\n\nhttps://www.telegraph.co.uk/global-health/science-and-disease/pfizer-coronavirus-vaccine-no-longer-needs-kept-super-cold-temperatures/\n\nUpdated stability data\n\nNormal medical freezer, -15C and -25C for up to two weeks \n\nInstead of -60C to -80C\n\nKept in a fridge for five days\n\nAwaiting US Food and Drug Administration (FDA) approval\n\n(Moderna, normal fridge temperature, 2C and 8C for 30 days)\n\nVaccine passports\n\nProfessor Dominic Wilkinson, Medical Ethics, Oxford University\n\nI think there\u2019s a strong ethical case for exploring immunity passports as a way forward, as a way of looking forward to more freedoms\n\nopen up some options in travel that are not there at the moment\n\nIf there was good evidence that you weren\u2019t at risk of spreading the virus, \n\nsuch a passport might then allow you to be waived from quarantine.\u201d\n\nwould be a cost to waiting until more people are immunised to roll out the passports.\n\nDigital vaccine passports\n\nBahrain\n\nDenmark\n\nSweden\n\nSecret antiviral meds?\n\nhttps://www.telegraph.co.uk/global-health/science-and-disease/coronavirus-news-vaccine-r-rate-covid-lockdown-end-cases-deaths/\n\neSwatini's King Mswati III (Swaziland)\n\ntested positive in January, now negative\n\nsaid he had recovered from Covid-19\n\nTaiwan President Tsai Ing-wen sent antiviral medication\n\nRecombination variant\n\nhttps://www.nyas.org/events/2021/webinar-the-quest-for-a-covid-19-vaccine/\n\nhttps://www.newscientist.com/article/2268379-two-coronavirus-variants-have-merged-heres-what-you-need-to-know/\n\nhttps://www.sciencedirect.com/science/article/pii/B9780128096338209588\n\nThe UK and California variants, B.1.1.7 and B.1.429\n\nCombined genomes into a heavily mutated hybrid\n\nDiscovered in a virus sample in Los Alamos, National Laboratory\n\nMay be how SARS-CoV-2 originated\n\nOne cell, two viral variants\n\nMultiple variants in circulation, more likely to occur\n\nWorst outcome, more transmissible and more antibody resistant", "link": "https://www.youtube.com/watch?v=is7XpudFGJ8", "date_published": "2021-02-20 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Encouraging Israeli vaccine data", "description": "Estimating the effectiveness of the Pfizer COVID-19 BNT162b2 vaccine after a single dose. A reanalysis of a study of \u2018real-world\u2019 vaccination outcomes from Israel\n\nAnalysis completed 1st February\n\nhttps://www.medrxiv.org/content/10.1101/2021.02.01.21250957v1?fbclid=IwAR1mnoVZiabuYtzRCsJhwDGmiOeT2yKfbHLbF6b2kx7tWPwQiDEMEGViTtI\n\nNorwich Medical School \n\nWe extract the primary data from Israel to,\n\nestimate the incidence per day for each day after the first injection\n\nN = 500,000\n\nRetrospective cohort study \n\nInfections over first 24 days = 3,077\n\nDays 0 to 8\n\nCase numbers increased (x 2)\n\nDay 0 to day 14\n\nEstimated vaccine effectiveness was pretty much zero\n\nDay 8 to day 21\n\nNew cases declined\n\n\nAt day 21\n\nVaccine effectiveness, 91%\n\nAfter day 21\n\nRemained at 90%\n\nExpected to last form 9 weeks to 6 months\n\nConclusion\n\nA single dose of vaccine is highly protective\n\nThe early results coming from Israel support the UK policy of extending the gap between doses\n\nAlso\n\nVaccine effectiveness seems to be better at reducing severe disease that at reducing mild disease\n\nTherefore, more than 90% protection against severe disease, hospitalisation and deaths\n\nJapan\n\nhttps://news.trust.org/item/20210219031629-aeqnu/\n\nConfirmed 91 VOC cases, E484K mutation\n\nInfection cluster, Tokyo immigration facility\n\nIt may be more contagious than conventional strains, \n\nand if it continues to spread domestically,\n\nit could lead to a rapid rise in cases\n\nOther VOCs, 151\n\nUK data \n\nhttps://coronavirus.data.gov.uk/details/cases\n\nCases, + 12,057 = 4,083,242\n\nDeaths, + 454 = 119,387\n\nDeaths, + 7,820 = 129,498\n\nVaccinations\n\nFirst dose, 16,423,082\n\nSecond dose, 573,724\n\nW/E 14 February, 2,908,155\n\n\nUS, CDC data\n\nhttps://covid.cdc.gov/covid-data-tracker/#trends_dailytrendscases\n\nPast 7 days\n\nhttps://www.washingtonpost.com/graphics/2020/national/coronavirus-us-cases-deaths/?itid=sf_coronavirus\n\nNew daily reported cases, down 28.1%\n\nNew daily reported deaths, 26.4%\n\nCoViD related hospitalizations, down 16.1\n\n(62,300)\n\nTest positivity rate, 5.1%\n\nVaccine doses since 14th December, 58,702,000\n\nTwo doses, 16,414,000 (5.02%)\n \nhttps://covidtracking.com/data\n\n\nGlobal vaccine tracker\n\nhttps://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/\n\nUK vaccine tracker\n\nhttps://coronavirus.data.gov.uk/details/vaccinations\n\nUS vaccine tracker\n\nhttps://covid.cdc.gov/covid-data-tracker/#vaccinations\n\nEurope vaccine tracker\n\nhttps://data.spectator.co.uk/city/vaccines\n\n\nUK vaccine donations\n\nUK has ordered 400 million doses\n\nhttps://www.bbc.co.uk/news/uk-politics-56117120\n\nPM, G7, donate most of the UK's surplus vaccine supply to poorer countries\n\nNumbers going will depend on boosters required\n\nUrges 100-day vaccine target\n\nEmmanuel Macron, 4 to 5%\n\n James Cleverly\n\nlooking at a figure significantly greater than that\n\nNo short-term diplomatic leverage\n\nglobal force for good\n\nUnlike some countries\n\nPartly using Covax\n\nUK, \u00a3548m\n\nUS, $4bn", "link": "https://www.youtube.com/watch?v=Xo2QQTmbECQ", "date_published": "2021-02-19 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]